Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPI 1020 in COPD Patients
NCT00483743Phase 2Completed
- Sponsor
- Syntara Limited
- Start
- Nov 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tpi-1020 in chronic obstructive pulmonary disease (COPD), sponsored by Syntara Limited. Started Nov 2007; status: completed.
02
Drugs
tpi-1020
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00483743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483743.